Renal lesions in HIV-1-positive patient treated with tenofovir

被引：97

作者：

Créput, C

Gonzalez-Canali, G

Hill, G

Piketty, C

Kazatchkine, M

Nochy, D

机构：

[1] Hop Europeen Georges Pompisou, Dept Pathol, Paris, France

[2] Hop Europeen Georges Pompisou, Dept Immunol, Paris, France

[3] Hop Broussais, INSERM, U430, F-75674 Paris, France

来源：

AIDS | 2003年 / 17卷 / 06期

关键词：

D O I：

10.1097/00002030-200304110-00026

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：935 / 937

页数：3

相关论文

共 4 条

[1] Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs
Cihlar, T
Ho, ES
Lin, DC
Mulato, AS
[J]. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) : 641 - 648
[2] Dobkin JF, 2002, INFECT MED, V19, P11
[3] Cidofovir-induced end-stage renal failure
Meier, P
Dautheville-Guibal, S
Ronco, PM
Rossert, J
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (01) : 148 - 149
[4] Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study
Schooley, RT
Ruane, P
Myers, RA
Beall, G
Lampiris, H
Berger, D
Chen, SS
Miller, MD
Isaacson, E
Cheng, AK
[J]. AIDS, 2002, 16 (09) : 1257 - 1263